Nuclear localization of mammary serine protease inhibitor (MASPIN): is its impact on the prognosis in laryngeal carcinoma due to a proapoptotic effect?

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 29, Issue 3, 2008, Pages 156-162

  Marioni, Gino ^a   Giacomelli, Luciano ^a   D'Alessandro, Emiliano ^a   Marchese Ragona, Rosario ^a   Staffieri, Claudia ^a   Ferraro, Silvia M ^a   Staffieri, Alberto ^a   Blandamura, Stella ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMARY SERINE PROTEASE INHIBITOR; SERINE PROTEINASE INHIBITOR;

AGED; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURVIVAL; CELLULAR DISTRIBUTION; DISEASE FREE INTERVAL; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL RATE; SURVIVAL TIME;

AGED; APOPTOSIS; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; NEOPLASM STAGING; PROGNOSIS; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 42749092582     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2007.04.010     Document Type: Article

References (25)

1. Zhang W., Shi H.Y., and Zhang M. Maspin overexpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins. BMC Cancer 5 (2005) 50
2. Lockett J., Yin S., Li X., et al. Tumor suppressive maspin and epithelial homeostasis. J Cell Biochem 97 (2006) 651-660
3. Rupa J.D., de Bruine A.P., Leers M.P.G., et al. Simultaneous detection of apoptosis and proliferation in colorectal carcinoma by multiparameter flow cytometry allows separation of high and low-turnover tumors with distinct clinical outcome. Cancer 97 (2003) 2404-2411
4. Koornstra J.J., Rijcken F.E.M., de Jong S., et al. Assessment of apoptosis by M30 immunoreactivity and the correlation with morphological criteria in normal colorectal mucosa, adenomas and carcinomas. Histopathology 44 (2004) 9-17
5. International Union Against Cancer. TNM classification of malignant tumours. 5th ed. (1997), Wiley-Liss, New York
6. In: Inouè S., and Spring K.R. (Eds). Video microscopy. The fundamentals. 2nd ed. (1986), Plenum Press, New York
7. Shannon C.E. Communication in the presence of noise. Proc Inst Radio Eng 37 (1949) 10-21
8. Marioni G., Blandamura S., Giacomelli L., et al. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease free interval after surgery for squamous cell carcinoma of the larynx. Histopathology 46 (2005) 576-582
9. Ueno T., Toi M., and Linder S. Detection of epithelial cell death in the body by cytokeratin 18 measurement. Biomed Pharmacother 59 (2005) S359-S362
10. Latha K., Zhang W., Cella N., et al. Maspin mediates increased tumour cell apoptosis upon induction of the mitochondrial permeability transition. Mol Cell Biol 25 (2005) 1737-1748
11. Russo A., Terrasi M., Agnese V., et al. Apoptosis: a relevant tool for anticancer therapy. Ann Oncol 17 Suppl 7 (2006) vii115-vii123
12. Carr N.J. M30 expression demonstrates apoptotic cells, correlates with in situ end-labeling, and is associated with Ki-67 expression in large intestinal neoplasms. Arch Pathol Lab Med 124 (2000) 1768-1772
13. Duan W.R., Garner D.S., Williams S.D., et al. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol 199 (2003) 221-228
14. Cuello-Carrion F.D., and Ciocca D.R. Improved detection of apoptotic cells using a modified in situ TUNEL technique. J Histochem Cytochem 47 (1999) 837-839
15. Bardales R.H., Xie S.S., and Hsu S.M. In situ DNA fragmentation assay for detection of apoptosis in paraffin-embedded tissue sections: technical considerations. Am J Clin Pathol 107 (1997) 332-336
16. Grassi A., Susca M., Ferri S., et al. Detection of the M30 neoepitope as a new tool to quantify liver apoptosis timing and patterns of positivity on frozen and paraffin-embedded sections. Am J Clin Pathol 121 (2004) 211-219
17. Leers M.P.G., Kölgen W., Björklund V., et al. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 187 (1999) 567-572
18. Backus H.H.J., Van Groeningen C.J., Vos W., et al. Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours and liver metastases. J Clin Pathol 55 (2002) 206-211
19. Liu J., Yin S., Reddy N., et al. Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res 64 (2004) 1703-1711
20. Chen E.I., Florens L., Axelrod F.T., et al. Maspin alters the carcinoma proteome. FASEB J 19 (2005) 1123-1124
21. Jiang N., Meng Y., Zhang S., et al. Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 21 (2002) 4089-4098
22. Marioni G., D'Alessandro E., Giacomelli L., et al. Maspin nuclear localization is related to reduced density of tumour-associated microvessels in laryngeal carcinoma. Anticancer Res 26 (2006) 4927-4932
23. Sood A.K., Fletcher M.S., Gruman L.M., et al. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8 (2002) 2924-2932
24. Mohsin S.K., Zhang M., Clark G.M., et al. Maspin expression in invasive breast cancer: association with other prognostic factors. J Pathol 199 (2003) 432-435
25. Beltran A., Parikh S., Liu Y., et al. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors. Oncogene 26 (2007) 2791-2798